mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.9 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |